Pharmaceuticals - Community Register

  

Community list of not active orphan medicinal products


WITHDRAWN  

Product information

Pomalidomide

EU orphan designation number: EU/3/10/759
Active ingredient: Pomalidomide
Indication: Treatment of post-essential thrombocythaemia myelofibrosis
Sponsor: Celgene Europe Limited
1 Longwalk Road, Stockley Park, Uxbridge, Middlesex UB11 1DB, United Kingdom

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
30/07/2010 Orphan designation EMA/OD/049/10 (2010)5342 of 27/07/2010
30/05/2011 Change of name and/or address of sponsor EMA/OD/049/10